Strategic Family Wealth Counselors’s AbbVie ABBV Stock Holding History

Strategic Family Wealth Counselors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$854K	Hold	3,394	–	–	0.2%	84
2026 Q1	$738K	Sell	3,394 -2,208	-39%	-$490K	0.19%	85
2025 Q4	$1.2M	Buy	5,602 +2,207	+65%	+$503K	0.27%	72
2025 Q3	$786K	Buy	3,395 +6	+0.2%	+$1.22K	0.2%	74
2025 Q2	$629K	Sell	3,389 -5	-0.1%	-$929	0.18%	78
2025 Q1	$711K	Buy	3,394 +23	+0.7%	+$4.47K	0.23%	69
2024 Q4	$599K	Buy	3,371 +494	+17%	+$90.8K	0.2%	73
2024 Q3	$568K	Buy	2,877 +33	+1%	+$6.16K	0.2%	73
2024 Q2	$488K	Sell	2,844 -75	-3%	-$12.4K	0.19%	70
2024 Q1	$532K	Buy	2,919 +75	+3%	+$12.9K	0.21%	64
2023 Q4	$441K	Hold	2,844	–	–	0.18%	67
2023 Q3	$424K	Hold	2,844	–	–	0.2%	62
2023 Q2	$383K	Hold	2,844	–	–	0.18%	67
2023 Q1	$453K	Hold	2,844	–	–	0.21%	58
2022 Q4	$460K	Sell	2,844 -2	-0.1%	-$307	0.23%	61
2022 Q3	$382K	Sell	2,846 -12	-0.4%	-$1.72K	0.19%	58
2022 Q2	$438K	Buy	2,858 +100	+4%	+$15.3K	0.21%	56
2022 Q1	$447K	Hold	2,758	–	–	0.18%	62
2021 Q4	$373K	Hold	2,758	–	–	0.12%	72
2021 Q3	$298K	Buy	+2,758	New	+$315K	0.1%	67

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Strategic Family Wealth Counselors's ABBV Position: Q2 2026 in Review

Strategic Family Wealth Counselors held its AbbVie (ABBV) position steady in Q2 2026 at 3,394 shares worth $854K. The position accounts for 0.2% of the portfolio, ranked #84.

Strategic Family Wealth Counselors first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.2M in Q4 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Strategic Family Wealth Counselors held 3,394 shares of AbbVie worth $854K as of Q2 2026.
Strategic Family Wealth Counselors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.2% of Strategic Family Wealth Counselors's portfolio in Q2 2026, its #84 holding.
Strategic Family Wealth Counselors first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
Strategic Family Wealth Counselors's AbbVie position peaked at $1.2M in Q4 2025.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Strategic Family Wealth Counselors's 13F filing for Q2 2026, filed 14 Aug 2026.